NCT00023842 - BCG With or Without Mitomycin in Treating Patients With Bladder Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

February 28, 2005

Conditions

Bladder Cancer

Interventions

BIOLOGICAL

BCG vaccine

DRUG

mitomycin C

PROCEDURE

adjuvant therapy

PROCEDURE

conventional surgery

Trial Locations (16)

1090

Academisch Ziekenhuis der Vrije Universiteit Brussel, Brussels

3500

Virga Jesse Hospital, Hasselt

21100

Ospedale di Circolo e Fondazione Macchi, Varese

28100

Azienda Ospedaliera Maggiore Della Carita, Novara

35340

Dokuz Eylul University School of Medicine, Izmir

56126

Universita Degli Studi Di Pisa, Pisa

B-9300

Onze Lieve Vrouw Ziekenhuis Aalst, Aalst

B-9000

Universitair Ziekenhuis Gent, Ghent

B-8500

Cazk Groeninghe - Campus Maria's Voorzienigheid, Kortrijk

1105 AZ

Academisch Medisch Centrum, Amsterdam

6202 AZ

Academisch Ziekenhuis Maastricht, Maastricht

NL-6500 HB

University Medical Center Nijmegen, Nijmegen

3008 AE

Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam

P-2700

Hospital Desterro, Amadora

BS2 8HW

Bristol Royal Infirmary, Bristol

CF14 4XN

University of Wales College of Medicine, Cardiff

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK